333 related articles for article (PubMed ID: 17492805)
1. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections.
Bachmann MF; Wolint P; Walton S; Schwarz K; Oxenius A
Eur J Immunol; 2007 Jun; 37(6):1502-12. PubMed ID: 17492805
[TBL] [Abstract][Full Text] [Related]
2. Protective immunity from naive CD8+ T cells activated in vitro with MHC class I binding immunogenic peptides and IL-2 in the absence of specialized APCs.
Hauser C; Zipprich F; Leblond I; Wirth S; Hügin AW
J Immunol; 1999 Jul; 163(1):330-6. PubMed ID: 10384132
[TBL] [Abstract][Full Text] [Related]
3. The role of the common cytokine receptor gamma-chain in regulating IL-2-dependent, activation-induced CD8+ T cell death.
Dai Z; Arakelov A; Wagener M; Konieczny BT; Lakkis FG
J Immunol; 1999 Sep; 163(6):3131-7. PubMed ID: 10477579
[TBL] [Abstract][Full Text] [Related]
4. Tolerant CD8 T cells induced by multiple injections of peptide antigen show impaired TCR signaling and altered proliferative responses in vitro and in vivo.
Dubois PM; Pihlgren M; Tomkowiak M; Van Mechelen M; Marvel J
J Immunol; 1998 Nov; 161(10):5260-7. PubMed ID: 9820498
[TBL] [Abstract][Full Text] [Related]
5. A novel approach to visualize polyclonal virus-specific CD8 T cells in vivo.
Zimmermann C; Pircher H
J Immunol; 1999 May; 162(9):5178-82. PubMed ID: 10227990
[TBL] [Abstract][Full Text] [Related]
6. In vivo state of antiviral CTL precursors. Characterization of a cycling cell population containing CTL precursors in immune mice.
Razvi ES; Welsh RM; McFarland HI
J Immunol; 1995 Jan; 154(2):620-32. PubMed ID: 7529281
[TBL] [Abstract][Full Text] [Related]
7. Endogenous IL-2 contributes to T cell expansion and IFN-gamma production during lymphocytic choriomeningitis virus infection.
Cousens LP; Orange JS; Biron CA
J Immunol; 1995 Dec; 155(12):5690-9. PubMed ID: 7499855
[TBL] [Abstract][Full Text] [Related]
8. CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses.
Whitmire JK; Flavell RA; Grewal IS; Larsen CP; Pearson TC; Ahmed R
J Immunol; 1999 Sep; 163(6):3194-201. PubMed ID: 10477587
[TBL] [Abstract][Full Text] [Related]
9. Defining parameters for successful immunocytotherapy of persistent viral infection.
Berger DP; Homann D; Oldstone MB
Virology; 2000 Jan; 266(2):257-63. PubMed ID: 10639312
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo.
Schluns KS; Kieper WC; Jameson SC; Lefrançois L
Nat Immunol; 2000 Nov; 1(5):426-32. PubMed ID: 11062503
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant effect of IL-12: conversion of peptide antigen administration from tolerizing to immunizing for CD8+ T cells in vivo.
Schmidt CS; Mescher MF
J Immunol; 1999 Sep; 163(5):2561-7. PubMed ID: 10452994
[TBL] [Abstract][Full Text] [Related]
12. Selective activation of CD8 T cell effector functions by epitope variants of lymphocytic choriomeningitis virus glycoprotein.
Martin S; Kohler H; Weltzien HU; Leipner C
J Immunol; 1996 Sep; 157(6):2358-65. PubMed ID: 8805633
[TBL] [Abstract][Full Text] [Related]
13. Donor cell persistence and activation-induced unresponsiveness of peripheral CD8+ T cells.
Ehl S; Barchet W; Oehen S; Aichele P; Hombach J; Hengartner H; Zinkernagel RM
Eur J Immunol; 2000 Mar; 30(3):883-91. PubMed ID: 10741405
[TBL] [Abstract][Full Text] [Related]
14. Thymic selection and peptide-induced activation of T cell receptor-transgenic CD8 T cells in interleukin-2-deficient mice.
Krämer S; Mamalaki C; Horak I; Schimpl A; Kioussis D; Hüng T
Eur J Immunol; 1994 Oct; 24(10):2317-22. PubMed ID: 7925559
[TBL] [Abstract][Full Text] [Related]
15. IL-2 can support growth of CD8+ T cells but not CD4+ T cells of human IL-2 receptor beta-chain transgenic mice.
Asano M; Ishida Y; Sabe H; Kondo M; Sugamura K; Honjo T
J Immunol; 1994 Dec; 153(12):5373-81. PubMed ID: 7989743
[TBL] [Abstract][Full Text] [Related]
16. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
[TBL] [Abstract][Full Text] [Related]
17. Activated T lymphocytes from mice infected by lymphocytic choriomeningitis virus display high affinity IL-2 receptors but do not proliferate in response to IL-2.
Saron MF; Colle JH; Dautry-Varsat A; Truffa-Bachi P
J Immunol; 1991 Dec; 147(12):4333-7. PubMed ID: 1753103
[TBL] [Abstract][Full Text] [Related]
18. Immune down-regulation and peripheral deletion of CD8 T cells does not require TNF receptor-ligand interactions nor CD95 (Fas, APO-1).
Reich A; Körner H; Sedgwick JD; Pircher H
Eur J Immunol; 2000 Feb; 30(2):678-82. PubMed ID: 10671226
[TBL] [Abstract][Full Text] [Related]
19. IL-2 receptor alpha-chain expression is independently regulated in primary and secondary lymphoid organs.
Demaison C; Fiette L; Blanchetière V; Schimpl A; Thèze J; Froussard P
J Immunol; 1998 Aug; 161(4):1977-82. PubMed ID: 9712069
[TBL] [Abstract][Full Text] [Related]
20. Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis.
Han SB; Park SH; Jeon YJ; Kim YK; Kim HM; Yang KH
J Pharmacol Exp Ther; 2001 Nov; 299(2):415-25. PubMed ID: 11602650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
